Tytuł artykułu
Identyfikatory
Warianty tytułu
Języki publikacji
Abstrakty
Chiral triazine condensing reagents were obtained in situ by treatment 2-chloro-4,6-dimethoxy-1,3,5-triazine with strychnine, brucine, sparteine, nicotine and quinine, and used for enantioselective activation of racemic N-benzoyl derivatives of 2-methylserine, 2-isobutylserine and 2-benzylserine affording enantiomerically enriched appropriate 2-phenyl-4-hydroxymethyl-4-substituted-1,3-oxazolin-5-one. Configuration and ee of products were determined by HPLC on chiral stationary phase. S configuration of enantiomer activated faster to oxazolinone was confirmed for all chiral amines except quinine. For the later amine, R enantiomer of N-benzoyl-2-methylserine was activated faster. For experiments involving strychnine as chiral auxiliary, enantiomeric enrichmentwas substantially lower than in the case of proteinogenic amino acids and increased with the size of C alfa-substituent from 12% ee for methyl to 36% ee for isobutyl side chain.
Wydawca
Czasopismo
Rocznik
Tom
Strony
1817--1824
Opis fizyczny
Bibliogr. 21 poz., rys.
Twórcy
autor
autor
autor
autor
- Institute of Organic Chemistry, Łódź University of Technology, Żeromskiego 116, 90-924 Łódź, Poland
Bibliografia
- 1. For the review see: a) Wipf P. and Venkatraman S., Synlett, l (1997); b) Deeks T., Croks P.A. and Waigh R.D., J. Med. Chem., 26,762 (1983); c) Riego E., HernandezD., Albericio F. and AlvarezM., Synthesis,1907 (2005); d) Hamada Y. and Shioiri T., Chem. Rev., 105, 4441 (2005).
- 2. a) Delia Monica C., Randazzo A., Bifulco G., Cimino R, Aquino M., Izzo L, De Riccardis F. And Gomez-Paloma L., Tetrahedron Lett., 43, 5707 (2002); b) Snider B.B. and Duvall J.R., Tetrahedron Lett., 44, 3067 (2003); c) Lichtenthaler F.W. and Trummlitz G., FEBS Letters, 38, 237 (1974).
- 3. Matsukawa Y., Isobe M., Kotsuki H. and Ichikawa Y., J. Org. Chem,, 70, 5339 (2005).
- 4. Yakura T., Yoshimoto Y, Ishida C. and Mabuchi S., Synlett, 930 (2006).
- 5. a) Chen J. and Sandkuhler J., Neuroscience, 98, 141 (2000); b) Thomsen C. and Ole D.N., Neuropharmacology, 37, 1465 (1998); c) Chapman A.G., Talebi A., Yip P.K. and Meldrum B.S., Eur. J.Pharm., 424, 107 (2001); d) Moldrich R.X., Talebi A., Beart RM., Chapman A.G. and Meldrum B.S., Neuroscience Lett., 299, 125 (2001); e) Gubellini R, Saulle E., Centonze D., Costa C., Tropepi D., Bernardi G., Conquet F. and Calabresi R, Neuropharmacology, 44, 8 (2003).
- 6. Smith N.D. and Goodman M., Org. Lett., 5, 1035 (2003).
- 7. a) Fukuyama T. and Xu L., J. Am. Chem. Soc., 115,8449 (l 993); b) Shao H., Zhu Q. and Goodman M.,J. Org. Chem., 60, 790 (1995); c) Wipf R, Venkatraman S. and Miller C.R, Tetrahedron Lett., 36, 3639 (1995).
- 8. a) Hatakeyama S., Fukuyama H., Mukugi Y. and Irie H., Tetrahedron Lett., 37, 4047 (1996); b) Enders D., Bartsch M. and Runsink J., Synthesis, 243 (1999); c) Kovacs-Kulyassa A., Herczegh P. and Sztaricskai F., Tetrahedron Lett., 37, 2499 (1996); d) Kovacs-Kulyassa A., Herczegh R and Sztaricskai R, Tetrahedron, 53,13883 (1997); e) Matsukawa Y, Isobe M., Kotsuki H. and Ichikawa Y, J. Org. Chem., 70, 5339 (2005); f) Horikawa M., Nakajima T. and Ohfune Y, Synlett, 609 (1998).
- 9. Avenoza A., Peregrina J.M. and San Martin E., Tetrahedron Lett., 44, 6413 (2003).
- 10. a) Eid C.N., Nicas T.I., Mullen D.L., Loncharich R.J. and Paschal J.W., Bioorg. Med. Chem. Lett., l, 2087 (1997); b) Chen M-H., Steiner M.G., Patchet A.A., Cheng K., Wei L., Chan W.W.S., Butler B., Jacks T.M. and Smith R.G., Bioorg. Med. Chem. Lett., 6, 2163 (1996); c) Meng-Hsin C., Steiner M.G., Patchett A.A., Kang C., Liente W. and Chan W.W.S., Bioorg. Med. Chem. Lett., 6, 2163 (1996).
- 11. a) Pavone V., Di Blasio B., Lombardi A., Maglio O., Isernia C., Pedone C., Benedetti E., Altmann E. and Mutter M., Int. J. Peptide Protein Res., 41,15 (1993); b) Zabrocki J., Redliński A.S. and Leplawy M.T., Int. J. Peptide Protein Res., 32, 544 (1988); c) Altman E., Altman K.H. and Mutter M., Angew. Chem.Int. Ed., 27, 858 (2003).
- 12. a) Kamiński Z.J. and Leplawy M.T., Synthesis, 292 (1974); b) Kamiński Z.J., Leplawy M.T. and Zabrocki J., Synthesis, 792 (1973).
- 13. Leplawy M.T. and Olma A., Polish J. Chem., 53, 353 (1979).
- 14. a) Horikawa M., Nakajima T. and Ohfune Y., Synlett, 253 (1997); b) Chen S., Amino Acids, 27, 277 (2004).
- 15. Shiraiva T., Suzuki M., Sakai Y., Nagasawa H., Takatani K., Noshi D. and Yamanashi K., Chem. Pharm.Bull., 50, 1362(2002).
- 16. Chenault H.K., Dahmer J. and Whitesides G.M., J. Am. Chem. Soc., 111, 6354 (1989).
- 17. For the review see: a) Ohfune Y. and Shinada T., Eur. J. Org. Chem., 5127 (2005); b) Davis F.A., Zhang Y., Rao A. and Zhang Z., Tetrahedron, 57, 6345 (2001); c) Belokon Y.N., Maleev Y.I., Saveleva T.F. and tkonnikovN.S., Russ. Chem. Buli Int. Ed., 50,1037 (2001); d) Schoellkopf U., Tetrahedron, 39, 2085 (1983); e) Seebach D., Aebi J.D., Gander-Coquoz M. andNaef R., Helv. Chim. Acta, 70, 1194 (1987); f) Najera C., Abellan T. and Sansano J., Eur. J. Org. Chem., 2809 (2000); g) Avenoza A., Cativiela C., Corzana F., Peregrina J.M., Sucunza D. and Zurbano M.M., Tetrahedron: Asymm., 12,949 (2001); h) Namba K., Kawasaki M., Takada L, Iwama S., Izumida M., Shinada T. and Ohfune Y., Tetrahedron Lett., 42, 3733 (2001); i) Park H., Lee J., Kang M.J., Lee Y-J., Jeong B-S., Lee J-H., Yoo M-S., Kim M-J., Choi S. and Jew S., Tetrahedron, 60,4243 (2004); j) Alezra V., Bonin M., Micouin L., Policar C. and Husson H-P., Eur. J. Org. Chem., 2589 (2001); k) Murga J., Portoles R., Falomir E. ,Carda M. and Marco J.A., Tetrahedron: Asymm., 16, 1807 (2005); 1) Matsushita M., Maeda H.
- and Kodama M., Rec. Res. Develop. Org. Chem., 6, 587 (2002).
- 18. Kamiński Z.J., Kolesińska B., Kamińska J.E. and Góra J., J. Org. Chem., 63, 4248 (2001). 19.Miyazawa T., Minowa H., Shindo Y. and Yamada T., J. Liq. Chromatogr. Relat. Technol., 23, 1061 (2000).
- 20. Olma A., Polish J.Chem., 70, 1442 (1996).
- 21. Kamiński Z.J. and Kolesińska B., unpublished results
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BUJ6-0007-0056
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.